Robust real-world evidence: optimising disease-modifying treatments for multiple sclerosis

被引:0
|
作者
C. McArthur
C. Daruwalla
M. Jayeskara
J. W. L. Brown
机构
[1] University of East Anglia,Norwich Medical School
[2] University of Cambridge,Department of Clinical Neurosciences
来源
Journal of Neurology | 2023年 / 270卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:5127 / 5129
页数:2
相关论文
共 50 条
  • [1] Robust real-world evidence: optimising disease-modifying treatments for multiple sclerosis
    Mcarthur, C.
    Daruwalla, C.
    Jayeskara, M.
    Brown, J. W. L.
    JOURNAL OF NEUROLOGY, 2023, 270 (10) : 5127 - 5129
  • [2] Real-world persistence of multiple sclerosis disease-modifying therapies
    Tallantyre, Emma C.
    Dobson, Ruth
    Froud, Joseph L. J.
    St John, Frederika A.
    Anderson, Valerie M.
    Arun, Tarunya
    Buckley, Lauren
    Evangelou, Nikos
    Ford, Helen L.
    Galea, Ian
    George, Sumi
    Gray, Orla M.
    Hibbert, Aimee M.
    Hu, Mo
    Hughes, Stella E.
    Ingram, Gillian
    Kalra, Seema
    Lim, Chia-Hui E.
    Mathews, Joela T. M.
    McDonnell, Gavin V.
    Mescall, Naomi
    Norris, Sam
    Ramsay, Stephen J.
    Rice, Claire M.
    Russell, Melanie J.
    Shawe-Taylor, Marianne J.
    Williams, Thomas E.
    Harding, Katharine E.
    Robertson, Neil P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (07)
  • [3] Real-world effectiveness of oral disease-modifying therapies for multiple sclerosis
    Thanh Phuong Pham Nguyen
    Thibault, Dylan
    Willis, Allison
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 124 - 125
  • [4] Multiple sclerosis disease-modifying drug use by immigrants: a real-world study
    Graf, Jonas
    Ng, Huah Shin
    Zhu, Feng
    Zhao, Yinshan
    Wijnands, Jose M. A.
    Evans, Charity
    Fisk, John D.
    Marrie, Ruth Ann
    Tremlett, Helen
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [5] Real-World Effectiveness of Initial Disease-Modifying Therapies in Pediatric Multiple Sclerosis
    Krysko, Kristen M.
    Graves, Jennifer S.
    Rensel, Mary
    Weinstock-Guttman, Bianca
    Rutatangwa, Alice
    Aaen, Gregory
    Belman, Anita
    Benson, Leslie
    Chitnis, Tanuja
    Gorman, Mark
    Goyal, Manu S.
    Harris, Yolanda
    Krupp, Lauren
    Lotze, Timothy
    Mar, Soe
    Moodley, Manikum
    Ness, Jayne
    Rodriguez, Moses
    Rose, John
    Schreiner, Teri
    Tillema, Jan-Mendelt
    Mas, Michael Waltz
    MStat, T. Charles Casper
    Waubant, Emmanuelle
    ANNALS OF NEUROLOGY, 2020, 88 (01) : 42 - 55
  • [6] Multiple sclerosis disease-modifying drug use by immigrants: a real-world study
    Jonas Graf
    Huah Shin Ng
    Feng Zhu
    Yinshan Zhao
    José M. A. Wijnands
    Charity Evans
    John D. Fisk
    Ruth Ann Marrie
    Helen Tremlett
    Scientific Reports, 13
  • [7] Stopping Disease-Modifying Treatments in Multiple Sclerosis: A Systematic Review and Meta-Analysis of Real-World Studies
    Prosperini, Luca
    Haggiag, Shalom
    Ruggieri, Serena
    Tortorella, Carla
    Gasperini, Claudio
    CNS DRUGS, 2023, 37 (10) : 915 - 927
  • [8] Stopping Disease-Modifying Treatments in Multiple Sclerosis: A Systematic Review and Meta-Analysis of Real-World Studies
    Luca Prosperini
    Shalom Haggiag
    Serena Ruggieri
    Carla Tortorella
    Claudio Gasperini
    CNS Drugs, 2023, 37 : 915 - 927
  • [9] Real-World Effectiveness of Disease-Modifying Therapies in Korean Patients with Relapsing Multiple Sclerosis
    Kim, Su-Hyun
    Park, Min Su
    Kim, Woojun
    Huh, So-Young
    Shin, Hyun-June
    Hyun, Jae-Won
    Kim, Ho Jin
    JOURNAL OF CLINICAL NEUROLOGY, 2019, 15 (01): : 20 - 26
  • [10] Comparative Efficacy of Disease-Modifying Treatments for Relapsing Multiple Sclerosis-Variations in Real-World Experience-Reply
    Roos, Izanne
    Kalincik, Tomas
    JAMA NEUROLOGY, 2024, 81 (01) : 87 - 88